News Focus
News Focus
Followers 28
Posts 4683
Boards Moderated 0
Alias Born 07/25/2007

Re: DewDiligence post# 10718

Friday, 07/26/2013 11:53:49 AM

Friday, July 26, 2013 11:53:49 AM

Post# of 20689
{{It means Teva's 2015 process patent is unenforceable and hence MNTA/NVS (and MYL) can launch generic Copaxone in May 2014, pending FDA approval.}}

Wow, MNTA finally had a legal decision go its way. I am in shock. Well, MNTA's lawyers weren't involved so maybe it isn't such a shock after all. :)